Caris Life Sciences, Inc.

Caris Life Sciences, Inc.

CAI
Caris Life Sciences, Inc.US flagNASDAQ Global Select
15.48
USD
-1.04
- -
4.38BMarket Cap

Income Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
258
306
412
812
+ Sales & Services Revenue
258
306
412
812
- Cost of Revenue
178
217
233
273
+ Cost of Goods & Services
178
217
233
273
Gross Profit
80
89
179
539
+ Other Operating Income
- -
- -
- -
- -
- Operating Expenses
396
409
436
494
+ Selling, General & Admin
295
292
322
392
+ Research & Development
101
117
114
102
+ Other Operating Expense
- -
- -
- -
- -
Operating Income (Loss)
-316
-320
-257
45
- Non-Operating (Income) Loss
5
22
25
113
+ Interest Expense, Net
26
20
43
40
+ Interest Expense
27
32
50
57
- Interest Income
1
11
7
16
+ Other Non-Op (Income) Loss
-21
2
-18
73
Pretax Income
-321
-341
-282
-68
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-321
-341
-282
-68
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-321
-341
-282
-68
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-321
-341
-282
-68
- Preferred Dividends
79
121
384
384
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-400
-463
-666
-453
EBIT
-316
-320
-257
45
EBITDA
-268
-271
-208
68
EBITDA Margin (%)
-103.49
-88.38
-50.5
8.34
EBITA
-316
-320
-257
45
Gross Margin (%)
30.96
29.17
43.37
66.4
Operating Margin (%)
-122.16
-104.38
-62.37
5.56
Profit Margin (%)
-124.12
-111.53
-68.38
-8.38
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
48
49
49
23
Basic Weighted Avg Shares
255
255
278
167
Basic EPS, GAAP
-1.57
-1.82
-2.4
-2.71
Basic EPS from Cont Ops
-1.26
-1.34
-1.01
-0.41
Diluted Weighted Avg Shares
255
255
278
167
Diluted EPS, GAAP
-1.57
-1.82
-2.4
-2.71
Diluted EPS from Cont Ops
-1.26
-1.34
-1.01
-0.41

Balance Sheet (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
516
243
216
998
+ Cash, Cash Equivalents & STI
410
122
66
799
+ Cash & Cash Equivalents
107
56
64
796
+ ST Investments
302
65
2
2
+ Accounts & Notes Receiv
40
55
88
112
+ Accounts Receivable, Net
40
49
88
112
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
7
- -
- -
+ Inventories
47
49
40
64
+ Raw Materials
47
49
40
64
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
19
17
22
23
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
201
170
128
128
+ Property, Plant & Equip, Net
138
148
68
63
+ Property, Plant & Equip
273
332
296
304
- Accumulated Depreciation
135
184
229
241
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
63
23
60
65
+ Total Intangible Assets
19
19
19
19
+ Goodwill
19
19
19
19
+ Other Intangible Assets
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
44
3
41
45
Total Assets
717
413
344
1,126
+ Payables & Accruals
56
61
61
64
+ Accounts Payable
27
27
28
39
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
28
34
33
25
+ ST Debt
57
7
66
7
+ ST Borrowings
53
- -
60
- -
+ ST Finance Leases
4
7
6
7
+ Other ST Liabilities
24
28
38
56
+ Deferred Revenue
1
6
7
24
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
23
22
31
32
Total Current Liabilities
137
95
165
127
+ LT Debt
214
211
358
421
+ LT Borrowings
170
166
319
378
+ LT Finance Leases
44
44
39
43
+ Other LT Liabilities
2,069
2,252
2,319
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
2,069
2,252
2,319
- -
Total Noncurrent Liabilities
2,283
2,463
2,677
421
Total Liabilities
2,420
2,558
2,843
548
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
- -
3,142
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
- -
3,142
- Treasury Stock
- -
- -
- -
17
+ Retained Earnings
-1,679
-2,119
-2,472
-2,549
+ Other Equity
2
- -
- -
1
Equity Before Minority Interest
-1,702
-2,145
-2,499
577
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-1,702
-2,145
-2,499
577
Total Liabilities & Equity
717
413
344
1,126
Shares Outstanding
278
278
278
283
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
49
51
45
49
Net Debt
115
110
315
-418
Net Debt to Equity
-6.77
-5.12
-12.62
-72.37
Tangible Common Equity Ratio
-246.6
-549.93
-776.28
50.43
Current Ratio
3.77
2.55
1.3
7.85
Cash Conversion Cycle
- -
88.79
85.48
72.88

Cash Flow Statement (USD)

APIChat
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-321
-341
-282
-68
+ Depreciation & Amortization
48
49
49
23
+ Non-Cash Items
9
23
17
162
+ Stock-Based Compensation
23
15
19
70
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
-14
8
-2
92
+ Chg in Non-Cash Work Cap
-22
-7
-29
-33
+ (Inc) Dec in Accts Receiv
-12
-15
-34
-30
+ (Inc) Dec in Inventories
-11
-4
5
-21
+ (Inc) Dec in Prepaid Assets
-4
5
-1
-5
+ Inc (Dec) in Accts Payable
2
8
1
23
+ Inc (Dec) in Other
2
-1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-286
-276
-245
83
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
-42
-22
-8
-16
+ Acq of Fixed Prod Assets
-42
-22
-8
-16
+ Acq of Intangible Assets
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
528
+ Increase in Capital Stock
- -
- -
- -
528
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
-241
237
61
- -
+ Dec in LT Investment
138
300
61
- -
+ Inc in LT Investment
-378
-63
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-283
215
53
-16
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
-1
11
200
28
+ Cash From Debt
- -
191
200
28
+ Repayments of Debt
-1
-181
- -
- -
+ Other Financing Activities
11
- -
- -
109
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
10
10
200
665
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
-558
-51
8
732
EBITDA
-268
-271
-208
68
EBITDA Margin (%)
-103.49
-88.38
-50.5
8.34
Free Cash Flow
-328
-298
-254
67
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-409
-438
-290
Free Cash Flow per Basic Share
-1.29
-1.17
-0.91
0.4
Price/Free Cash Flow
- -
- -
- -
45.38
Cash Flow to Net Income
0.89
0.81
0.87
-1.22
Capital Expenditures
-42
-22
-8
-16